Filter
832
Filtered Results: 832
Text search:
in
vitro
Featured
Recommendations
100
New Publications
147
Language
Document type
No document type
336
Guidelines
236
Studies & Reports
123
Manuals
70
Fact sheets
26
Strategic & Response Plan
24
Training Material
9
Situation Updates
4
Resource Platforms
3
Brochures
1
Countries / Regions
India
32
Latin America and the Carribbean
26
Germany
23
Russia
23
South Africa
20
Brazil
17
Global
17
Africa
13
Colombia
11
Western and Central Europe
11
Argentina
10
Kenya
9
Peru
9
Ethiopia
8
Zambia
8
Bolivia
8
Paraguay
8
Eastern Europe
7
Rwanda
6
Namibia
6
Ukraine
6
Venezuela
6
Burkina Faso
5
Uganda
5
Tanzania
5
Indonesia
5
El Salvador
5
Nigeria
4
Senegal
4
Cameroon
4
West and Central Africa
4
Middle East and North Africa
4
Sierra Leone
3
Congo, Democratic Republic of
3
Mali
3
Niger
3
Nepal
3
Benin
3
Eswatini/ Swaziland
3
Ecuador
3
Lesotho
3
Myanmar / Burma
3
East and Southern Africa
3
Eastern Europe and Central Asia
3
Congo-Brazzaville
3
France
3
Spain
3
Guinea
2
Liberia
2
Côte d’Ivoire / Ivory Coast
2
Haiti
2
Philippines
2
Syria
2
Chad
2
Bangladesh
2
Malawi
2
Angola
2
Madagascar
2
Chile
2
Yemen
2
Asia
2
Tajikistan
2
Kazakhstan
2
Guinea-Bissau
1
Morocco
1
USA
1
Saudi Arabia
1
Ghana
1
Togo
1
Zimbabwe
1
Somalia
1
South Sudan
1
Iraq
1
Jordan
1
Afghanistan
1
Lebanon
1
Turkey
1
Egypt
1
Thailand
1
Gambia
1
Mauritania
1
Mozambique
1
Sudan
1
Dominican Republic
1
North Macedonia
1
Serbia
1
Cuba
1
Burundi
1
Honduras
1
Libya
1
Guatemala
1
Mexico
1
Nicaragua
1
South–East Asia Region
1
Luxembourg
1
Albania
1
Djibouti
1
Armenia
1
Mongolia
1
Southern Africa
1
Laos
1
Canada
1
Qatar
1
Uzbekistan
1
Kyrgyzstan
1
Georgia
1
North America
1
Belgium
1
Tunisia
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
245
Clinical Guidelines
153
Pharmacy & Technologies
47
Public Health
24
Women & Child Health
23
Key Resources
18
Capacity Building
1
Toolboxes
COVID-19
157
TB
108
HIV
91
AMR
55
NTDs
44
Pharmacy
32
Ebola
29
Rapid Response
28
Zika
16
Caregiver
16
Planetary Health
15
Refugee
13
Mental Health
12
Polio
6
NCDs
6
Global Health Education
4
Conflict
3
Specific Hazards
3
Cholera
2
Natural Hazards
2
Disability
1
Social Ethics
1
3 March 2022
The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available ... pdf format (via the ‘Download’ button) and via an online platform, and is updated regularly as new evidence emerges.
2nd edition. The purpose of the WHO human health risk assessment toolkit: chemical hazards is to provide its users with guidance to identify, acquire and use the information needed to assess chemical hazards, exposures and the corresponding health risks in... their given health risk assessment contexts at local and/or national levels.
The Toolkit provides road maps for conducting a human health risk assessment, identifies information that must be gathered to complete an assessment and provides electronic links to international resources from which the user can obtain information and methods essential for conducting the human health risk assessment
Über SARS-CoV-2-Testsysteme informieren das Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) und das Paul-Ehrlich-Institut. Die Informationen ergänzen sich, den rechtlichen Rahmen bietet u.a. die Coronavirus-Testverordnung-TestV.
Das BfArM bietet eine Liste von Antigen-Tests zum dir...
These guidelines provide a framework for effective action to facilitate access to safe and ethical
testing services for different population groups. The implementation of the a comprehensive
approach, known as HIV Testing Services (HTS) is cardinal as an effective package of services
that diminis...
n the countries of the Region of the Americas, there are different forms of organization of health services at the first level of care. Some countries include certain laboratory, dental and diagnostic imaging practices in the first level of care, wh...
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f...
Buruli ulcer caused by Mycobacterium ulcerans is a neglected tropical disease characterized by extensive ulceration involving predominantly the upper and lower limbs of patients. The disease is common in rural tropical communities ... West and Central Africa, where access to proper health care is limited. Pathogenesis of the characteristic painless ulcers is linked to the elaboration by M. ulcerans of a lipid toxin called mycolactone that has potent cytopathic, immunosuppressive, and analgesic effects on a host of cells in cutaneous tissues. Mycolactone is known to profoundly inhibit secretion of a plethora of proteins that are essential for wound healing. Even though a combination antibacterial therapy of streptomycin and rifampicin for 8 weeks is effective for treatment, it relies on good and appropriate wound management to prevent secondary bacterial infections and improve healing. Evidence-based interventions for wound care in Buruli ulcer disease are often lacking and have relied on expert advice and recommendations. Surgical interventions are limited to debridement of necrotic tissue and grafting of extensive ulcers, usually after antibiotic therapy. Patients’ rehabilitation is an important component of care to reduce disabilities associated with the disease and proper integration into the community after treatment.
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards
the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized ...
GDF is the largest global provider of quality-assured tuberculosis (TB)
medicines, diagnostics, and laboratory supplies to the public sector.
Since 2001, GDF has facilitated access to high-quality TB care in over 130
countries, providing treatmen...
Report of the WHO/Bill & Melinda Gates Foundation Consultation. The Consultation was organized back-to-back with the first annual meeting of the International Coordinating Group of the BMGF-funded project for human and dog rabies elimination in deve...
Trypanosoma cruzi is the etiological agent of Chagas disease (CD), considered one of the most important parasitic infections in Latin America. Between 25 and 90 million humans are at infection risk via at least one of multiple infection mechanisms. ...
Full Perscribing information on Fexinidazole Tablet for oral use
INDICATIONS AND USAGE
Fexinidazole Tablets are indicated for the treatment of both the first-stage (hemolymphatic) and second-stage (meningoencephalitic) human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense ... patients 6 years of age and older and weighing at least 20 kg.
Limitations of Use
Due to the decreased efficacy observed in patients with severe second stage HAT (cerebrospinal fluid white blood cell count (CSF-WBC) >100 cells/μL) due to T. brucei gambiense disease, Fexinidazole Tablets should only be used in these patients if there are no other available treatment options [see Warnings and Precautions (5.1)]
Chromoblastomycosis (CMB) is a chronic fungal infection of the skin and the subcutaneous tissue caused by a transcutaneous traumatic inoculation of a specific group of dematiaceous fungi occurring mainly in tropical and subtropical zones worldwide. ...
Snakebite is an acute life threatening time limiting medical emergency. It is a preventable public
health hazard often faced by rural population in tropical and subtropical countries with heavy
rainfall and humid climate.
This guideline provides evidence-informed guidance on the use of non-sugar sweeteners to reduce the risk of unhealthy weight gain and diet-related noncommunicable diseases in adults and children. The guidance ... this guideline is not based on toxicological assessments of the safety of individual non-sugar sweeteners and is therefore not intended to update or replace guidance on safe or maximal levels of intake established by the Joint Food and Agriculture Organization of the United Nations (FAO)/WHO Expert Committee on Food Additives (JECFA) or other authoritative bodies.
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized <... two sections: the first section provides WHO insights on global vaccine market dynamics, drawing from data provided by Member States, which are, in turn, analysed and displayed in the second section.
This document is an output of a WHO cross-programme initiative aiming to improve the prevention, diagnosis and management of anaemia and thereby accelerate reduction in its prevalence. It comes at an important time, midway through the era of the Sus...
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID...
The document, "Sustainable Management of Radiotherapy Facilities and Equipment," by WHO and IAEA, provides guidelines for managing radiotherapy equipment and facilities to ensure effective and safe cancer treatment. It covers essential aspects like preventive and corrective maintenance, funding, inf...
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several ...
